Merck & Co Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (176)

Latest Posts

About This Stock More About This Stock
Healthcare (Top 30 Weights) Earnings Estimates And Revisions
Article By: T.J. Hayes
Monday, February 17, 2020 5:44 AM EST
The cumulative 2020 earnings power of these 30 stocks was revised down by -.34% in the past 60 days.
In this article: EW, HCA, HUM, JNJ, LLY, MDT, MRK, PFE, SYK, TMO, UNH, ILMN, AMGN, BIIB, GILD, ISRG, VRTX Also: ABT, AGN, BAX, BDX, BMY, BSX, CI, CNC, CVS, DHR, XLV, ZTS, ABBV, ANTM
Read
Merck Spin-Off Pits Cash Now Vs. Excitement Later
Article By: Lipper Alpha Insight
Thursday, February 6, 2020 4:43 AM EST
Merck (MRK) is joining the spin-off party. The $217 billion U.S. drugmaker led by Ken Frazier is joining Pfizer and GlaxoSmithKline with plans to separate some stable businesses from fast-growing products.
In this article: MRK
Read
Merck Reports Mixed Q4 Earnings
Article By: Benzinga
Wednesday, February 5, 2020 10:22 AM EST
Merck & Co reported quarterly earnings of $1.16 per share on Wednesday.
In this article: MRK
Read
5 Big Drug/Biotech Stocks Set To Trump Q4 Earnings Estimates
Article By: Zacks Investment Research
Wednesday, January 22, 2020 4:00 PM EST
A highlight of five big drug/biotech companies, which are expected to deliver positive earnings surprise in their upcoming quarterly earnings announcements.
In this article: AZN, MRK, ALXN, AMGN, ABBV
Read
DOW + (8 S&P 500 Top Weights) Earnings Estimates And Revisions
Article By: T.J. Hayes
Sunday, January 12, 2020 9:43 PM EST
The cumulative 2020 earnings power of these 38 stocks was revised down by -1.97% in the past 60 days [A significant portion of this downward revision is related to BA (short term markdown in EPS) – which will fully recover its earnings power 2021].
In this article: ATVXRVZSCOCATVXRVZSCO, ABT, AXP, BA, BAC, C, CAT, CVX, DIS, DOW, GS, HD, IBM, JNJ, JPM, KO, MA, MCD, MMM, MRK, NKE, PEP, PFE, PG, T, TRV, UNH, UTX, V, VZ, WFC, WMT, XOM, AAPL, CSCO, INTC, MSFT, WBA, DIA, SPY
Read

PARTNER HEADLINES

Latest Tweets for $MRK

No tweets yet!

$MRK

OncoSec Raising Its Profile In Fight Against Cancer
Harry Goldstein 9/7/2017 5:43:14 PM

I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.

OncoSec Raising Its Profile In Fight Against Cancer
Alexis Renault 9/6/2017 4:08:15 PM

Thanks for this info, Terry Chrisomalis. Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 3 of 3 comments